Powerful as individual solution – Unstoppable together
The new ZEISS Cataract Workflow
By connecting devices, data and applications, the ZEISS portfolio enables a seamless integration from office to OR and back.
You are on our international English website. This site features our entire product portfolio worldwide. The products featured may not be available in the US. If you are a citizen from the US, please visit your country website for local information and contacts.
Based on 20+ years experience, development and production, ZEISS provides a state-of-the-art ophthalmic viscosurgical devices (OVD) portfolio that supports your work at each step of the ophthalmic procedure. ZEISS OVDs originate from bacterial fermentation.1
Preoperative topical ampules containing sodium hyaluronate (0.3%) with lidocaine (2%) that coats and hydrates the epithelial cells supporting clear vision into the eye.
Intracameral viscous-cohesive OVD
Providing the optimal combination of a viscous-cohesive and a medium-viscosity dispersive OVD in two separate syringes. Giving you the space and protection you need in standard and complex cases – with fast and easy removal.
Cohesive part (incl. Z-HYALIN®plus)
Dispersive part (incl. Z-HYALCOAT®)
Combining a medium-viscosity dispersive and a viscous-cohesive viscoelastic in one syringe separated by an innovative bypass stopper system for a planned sequential injection. Providing an easy and unique approach to the soft-shell-technique.8
ZEISS OVDs available in 10 syringe multipacks:
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
VISTHESIA 1.0%
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.0
|
10
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
2 x topical ampules (see below*)
|
Hydrochloride
|
|||||||
VISTHESIA 1.5%
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.5
|
15
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
2 x topical ampules (see below*)
|
Hydrochloride
|
|||||||
*VISTHESIA topical ampule11
|
n/a
|
2 x topical ampules
|
Bacterial fermentation
|
2 x 0.3
|
Sodium Hyaluronate
|
2 x 0.3
|
2 x 3
|
|
Lidocaine
|
2.0
|
20
|
||||||
Hydrochloride
|
||||||||
VISTHESIA 1.0% intra12
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.0
|
10
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
Hydrochloride
|
||||||||
VISTHESIA 1.5% intra12
|
Viscous-cohesive
|
1 x intracameral syringe
|
Bacterial fermentation
|
0.8
|
Sodium Hyaluronate
|
1.5
|
15
|
|
1 x 27 G cannula
|
Lidocaine
|
1.0
|
10
|
|||||
Hydrochloride
|
||||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
COMBIVISC
|
Viscous-cohesive
|
1 x intracameral syringe
|
5 x intracameral syringes
|
Bacterial fermentation
|
1.0
|
Sodium Hyaluronate
|
1.5
|
15
|
1 x 25 G cannulas
|
5 x 25 G cannulas
|
|||||||
Medium-viscosity dispersive
|
1 x intracameral syringes
|
5 x intracameral syringes
|
Bacterial fermentation
|
0.85
|
Sodium Hyaluronate
|
3.0
|
30
|
|
1 x 25 G cannula
|
5 x 25 G cannulas
|
|||||||
TWINVISC
|
Medium-viscosity dispersive
|
1 x two-chamber intracameral syringe
|
-
|
Bacterial fermentation
|
0.7
|
Sodium Hyaluronate
|
2.2
|
22
|
1 x 25 G cannula
|
||||||||
Viscous-cohesive
|
1 x two-chamber intracameral syringe
|
-
|
Bacterial fermentation
|
0.7
|
Sodium Hyaluronate
|
1.0
|
10
|
|
1 x 25 G cannula
|
||||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
Z-CELCOAT
|
Low-viscosity dispersive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Botanical
|
2.1
|
Hydroxypropyl-methylcellulose
|
2.0
|
20
|
1 x 23 G cannula
|
10 x 23 G cannulas
|
|||||||
Z-HYALCOAT
|
Medium-viscosity dispersive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Bacterial fermentation
|
0.85
|
Sodium Hyaluronate
|
3.0
|
30
|
1 x 25 G cannula
|
10 x 25 G cannulas
|
|||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Classification
|
Single pack content
|
Multipack content
|
Origin
|
Volume (ml)
|
Substance
|
Concentration I (%)
|
Concentration II (mg/ml)
|
|
---|---|---|---|---|---|---|---|---|
Z-HYALIN
|
Viscous-cohesive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Bacterial fermentation
|
1.0
|
Sodium Hyaluronate
|
1.0
|
10
|
1 x 27 G cannula
|
10 x 27 G cannulas
|
|||||||
Z-HYALIN plus
|
Viscous-cohesive
|
1 x intracameral syringe
|
10 x intracameral syringes
|
Bacterial fermentation
|
1.0
|
Sodium Hyaluronate
|
1.5
|
15
|
1 x 27 G cannula
|
10 x 27 G cannulas
|
|||||||
Z-HYALON
|
Viscous-cohesive
|
10 x intracameral syringes |
10 x intracameral syringes |
Rooster comb
|
0.55 or 0.85
|
Sodium Hyaluronate
|
1.0
|
10
|
10 x 27 G cannulas |
10 x 27 G cannulas |
|||||||
Z-HYALON plus
|
Super-viscous cohesive
|
1 x intracameral syringe
|
-
|
Rooster comb
|
0.55 |
Sodium Hyaluronate
|
1.4
|
14
|
1 x 27 G cannula
|
||||||||
All OVDs are phthalate free and have a pH range between 6.8 and 7.6.
The shelf life for all OVDs is 3 years except for TWINVISC, which has a shelf life of 2 years
Except: Z-HYALON, Z-HYALON plus, Z-CELCOAT
VISTHESIA 1.0% and VISTHESIA 1.5% are not for sale in the UK or Portugal
F. Poyales-Galan, G. Pirazzoli: Clinical Evaluation of Endothelial Cell Decrease with VISTHESIA In: Phacoemulsification Surgery. JCRS Vol. 31, Nov. 2005
S. K. Pandey et al.: Evaluation of the cataractgenic effect of viscoanesthetic solutions on the rabbit crystalline lens. JCRS Vol. 31, July 2005
Harry Domack: Z-HYALIN Plus: A Versatile Cohesive Agent. Cataract & Refractive Surgery Today, Europe, July/August 2011
S. A. Arshinoff, M Jafari: New classification of ophthalmic viscosurgical devices. JCRS Vol. 31, Nov. 2005
W. W. Hütz et al.: Comparison of viscoelastic substances used in phacoemulsification. JCRS Vol. 22, Sept. 1996
ZEISS: TWINVISC – Two OVDs, one syringe, a unique concept (User testimonial by S. Arshinoff), 2011
G. U. Auffahrt et al.: Comparison of the performance and safety of 2 ophthalmic viscosurgical devices in cataract surgery. JCRS Vol. 43, Jan. 2017
A. D. Steele, V. Andrews: Methylcellulose for endothelial cell protection. Australian and New Zealand Journal of Ophthalmology Vol. 16, 1988
Not available individually; only available with VISTHESIA 1.0% or 1.5%
VISTHESIA intra version does not contain 2 topical ampules
Megadalton = 1 million Dalton
1Pa s = 1000 mPa s